Wednesday, July 6, 2022
Mitochondrial Health

OIS Gene Therapy Innovation Showcase 2021

Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.


Similar Posts

22 thoughts on “OIS Gene Therapy Innovation Showcase 2021
  1. $ONTX & $ATNF… get in the train before it leaves Trust me… one has a cure to inflammation and the opioid crisis and one of there main scientist is the “Godfather of Cannabis”

  2. Can I go on record and say that although I like Covaxin in large part because it is traditional and NOT genetic, I am okay with gene therapy for diseases for which there aren't other remedies like blindness. I just hope that genetic aspect paradox in these two products doesn't discourage Ocugen from occasionally stressing the more natural (non-genetic ) aspect of Covaxin, which is a draw for many people. Afterall with vaccines we are all starting out healthy, and non-genetic cures (like Covaxin, Coronavac etc) are available. Novavax also essentially non-genetic because the "genetic instructions" are delivered to a moth, never to a human. People will LIKE that. So hope Ocugen isn't shy about mentioning traditional aspect of Covaxin.

Leave a Reply

Your email address will not be published.